Pub. Date : 2020
PMID : 31892970
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer Cells. | Doxorubicin | tumor protein p53 | Homo sapiens |
2 | Therefore, the recombinant dual-target MDM2/MDMX inhibitor could reverse doxorubicin resistance via the activation of the TAB1/TAK1/p38 MAPK pathway in wild-type p53 multidrug-resistant BC. | Doxorubicin | tumor protein p53 | Homo sapiens |